We would like to let you know about a clinical research study that is available for patients diagnosed with Inclusion Body Myositis (IBM). The Yale School of Medicine, Department of Neurology, is currently seeking volunteers for study participation.
The purpose of this study is to use Electrical Impedance Myography (EIM), a painless, non-invasive diagnostic test to find and measure any obstructions in the flow of electric current through the muscle tissue of people with Inclusion Body Myositis (IBM).
The measurements we obtain from this assessment may possibly serve as a biomarker of disease. A ‘biomarker’ is any measurable substance that can be associated with disease progression and severity. Biomarkers may also be used to see how well the body responds to a treatment for a disease or condition.
The EIM procedure is completely painless and non-invasive. We will use electrodes placed on your skin to apply and measure a low intensity current signal passed through your muscles. This tells us how your muscles are working. The current is low voltage and does not make any changes to your muscles tissue or your skin, nor does it cause any feeling of shock or pain.
You may be eligible to participate in this study if you meet the following criteria:
- Male or Female, age > 45 years.
- Have clinico-pathologically defined IBM in the absence of any other significant neurological problem or cognitive dysfunction.
Your participation in the study is completely voluntary, and you have the right to participate or discontinue participation in the study at any time without penalty. Please be assured that all personal information will be kept confidential in accordance with applicable law.
Thank you in advance for your time and consideration.
If you would be interested in receiving more information about this study, please email Study Coordinator, Joan Nye (firstname.lastname@example.org), or Study Principal Investigator, Dr. Bhaskar Roy (email@example.com), or call us at 203-737-7095 or 203-785-6577.View Trial Details Tags: clinical trials inclusion body myositis myositis research